Blood Protein HMGB1 Identified as Key Player in Systemic Aging Transmission

A pioneering study reveals that the blood protein HMGB1 plays a crucial role in spreading aging signals across the body, offering new possibilities for anti-aging therapies.
Recent research from Korea University College of Medicine has uncovered a groundbreaking mechanism by which cellular aging may spread throughout the body via the bloodstream. The study highlights the role of a blood protein called HMGB1—specifically its redox-sensitive form, ReHMGB1—in promoting systemic senescence, which is a hallmark of aging.
Senescent cells, which accumulate with age, secrete various pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP). These factors impair tissue regeneration and contribute to tissue dysfunction. Although the local effects of senescent cells are well-known, how aging signals propagate across different tissues was previously unclear.
The research team demonstrated that ReHMGB1 circulates freely in the blood and induces aging features in distant tissues. Laboratory experiments with human cells showed that ReHMGB1 triggers senescence markers, such as p21 and p16, and promotes SASP factor expression. In mouse models, systemic administration of ReHMGB1 resulted in increased tissue aging signs and reduced muscle function.
Importantly, the study found that neutralizing HMGB1 with specific antibodies in middle-aged mice reduced senescence markers and improved muscle regeneration and physical performance. This suggests that targeting extracellular HMGB1 may offer a promising therapeutic strategy to combat age-related tissue decline.
Professor Ok Hee Jeon explained that aging signals are not confined to local cells but can be transmitted systemically through the bloodstream, with ReHMGB1 serving as a key driver. Interrupting this pathway could potentially restore tissue regenerative capacity and mitigate aging effects.
This innovative research opens new avenues for developing anti-aging therapies that focus on systemic factors like HMGB1. Collaborations with experts in aging biology, including Professors Irina Conboy and Christopher Wiley, underpin the significance of these findings for future medical applications.
Source: https://medicalxpress.com/news/2025-06-blood-protein-hmgb1-aging-body.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Enhancing Platelet Production by Targeting STAT1 and Epigenetic Pathways
A new study uncovers how inhibiting STAT1 boosts platelet generation from iPS cells by modulating the LIN28A-let-7 pathway, advancing ex vivo platelet manufacturing techniques.
Innovative Gene Therapy Technique Reactivates Inactive Genes Using DNA Editing
A new gene therapy approach using CRISPR-Cas9 reactivates dormant genes by bringing them closer to genetic switches, offering hope for treating blood disorders like sickle cell disease and beta-thalassemia.